We are using cookies to give you the best experience on our site. Cookies are files stored in your browser and are used by most websites to help personalise your web experience. By continuing to use our website without changing the settings, you are agreeing to our use of cookies.

Share
  • Facebook
  • Twitter
  • Linked In
  • Google+
back top
Successful First in Man Trial for MSC-based Cartilage Repair

1300 members from 70 countries Join ICRS

Successful First in Man Trial for MSC-based Cartilage Repair

Review of “Allogeneic MSCs and recycled autologous Chondrons mixed in a one-stage cartilage cell transplantation: A first-in-man trial in 35 patients” from STEM CELLS by Stuart P. Atkinson

Previous studies from the laboratory of Daniel B. F. Saris (University Medical Center Utrecht, The Netherlands) reported that a novel stem cell combination represented a safe and efficient means to repair cartilage in preclinical [1] and early clinical studies [2]. Their combination strategy involves allogeneic mesenchymal stem cells (MSCs) that provide trophic support to stimulate the cartilage-producing activity of patient-derived chondrons (chondrocytes with their native matrix) isolated while preparing the damaged cartilage for repair.

This successful strategy has now progressed to the next level, and a study in STEM CELLS provides a comprehensive description of the first-in-man trial in 35 patients and an 18-month follow-up [3].

Read More…

Review of “Allogeneic MSCs…
ICRShttps://cartilage.org/content/uploads/icrs.jpg
Successful First in Man Trial for MSC-based Cartilage Repair